150 related articles for article (PubMed ID: 8135581)
1. [Malignant mesothelioma: study of prognostic factors in a series of 188 cases].
Viallat JR; Boutin C; Rey F; Astoul P; Farisse P
Arch Anat Cytol Pathol; 1993; 41(5-6):205-11. PubMed ID: 8135581
[TBL] [Abstract][Full Text] [Related]
2. [Malignant mesothelioma: prognostic factors in a series of 125 patients studied from 1973 to 1987].
Boutin C; Rey F; Gouvernet J
Bull Acad Natl Med; 1992 Jan; 176(1):105-14; discussion 115-7. PubMed ID: 1606507
[TBL] [Abstract][Full Text] [Related]
3. Malignant pleural mesothelioma. Multivariate analysis of prognostic factors on 113 patients.
Fusco V; Ardizzoni A; Merlo F; Cinquegrana A; Faravelli B; De Palma M; Chessa L; Nicolò G; Serra M; Capaccio A
Anticancer Res; 1993; 13(3):683-9. PubMed ID: 8317897
[TBL] [Abstract][Full Text] [Related]
4. [Clinicopathological characteristics and prognosis of malignant pleural mesothelioma].
Chen WH; Zhang XL; Dai HP; Tong ZH; Zhang YH; Jin ML
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Nov; 36(11):825-8. PubMed ID: 24507393
[TBL] [Abstract][Full Text] [Related]
5. [Thoracoscopy in pleural mesothelioma].
Zhang DH; Gu YT; Pan WS
Zhonghua Jie He He Hu Xi Za Zhi; 1993 Jun; 16(3):150-3, 187. PubMed ID: 8242812
[TBL] [Abstract][Full Text] [Related]
6. Treatment results of 17 patients with diffuse pleural mesothelioma.
Liu CC; Hsu WH; Li WY; Huang MH
Ann Thorac Cardiovasc Surg; 1998 Oct; 4(5):233-9. PubMed ID: 9828278
[TBL] [Abstract][Full Text] [Related]
7. Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 2: Prognosis and staging.
Boutin C; Rey F; Gouvernet J; Viallat JR; Astoul P; Ledoray V
Cancer; 1993 Jul; 72(2):394-404. PubMed ID: 8319171
[TBL] [Abstract][Full Text] [Related]
8. A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma.
Lucchi M; Chella A; Melfi F; Dini P; Ambrogi M; Fino L; Fontanini G; Mussi A
Eur J Cardiothorac Surg; 2007 Mar; 31(3):529-33; discussion 533-4. PubMed ID: 17188885
[TBL] [Abstract][Full Text] [Related]
9. Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients.
Borasio P; Berruti A; Billé A; Lausi P; Levra MG; Giardino R; Ardissone F
Eur J Cardiothorac Surg; 2008 Feb; 33(2):307-13. PubMed ID: 18164622
[TBL] [Abstract][Full Text] [Related]
10. Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma.
Neragi-Miandoab S; Richards WG; Sugarbaker DJ
Int J Surg; 2008 Aug; 6(4):293-7. PubMed ID: 18585112
[TBL] [Abstract][Full Text] [Related]
11. [Endoscopic diagnosis of mesothelioma].
Boutin C; Frenay C; Astoul P
Rev Mal Respir; 1999 Dec; 16(6 Pt 2):1257-62. PubMed ID: 10897846
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of mesothelioma with interferon gamma and interleukin 2].
Boutin C; Viallat JR; Astoul P
Rev Pneumol Clin; 1990; 46(5):211-5. PubMed ID: 2127468
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors for 100 patients with malignant pleural mesothelioma.
Gonlugur U; Gonlugur TE
Arch Environ Occup Health; 2010; 65(2):65-9. PubMed ID: 20439224
[TBL] [Abstract][Full Text] [Related]
14. [Malignant mesothelioma of the pleura].
Erika V; Zoltán S; Miklós Z; Judit A; Akos L; Kálmán K
Orv Hetil; 1996 Feb; 137(5):233-8. PubMed ID: 8882441
[TBL] [Abstract][Full Text] [Related]
15. [Malignant pleural mesothelioma in 1997].
Viallat JR; Boutin C; Kasseyet S
Schweiz Med Wochenschr; 1997 Oct; 127(41):1707-11. PubMed ID: 9441378
[TBL] [Abstract][Full Text] [Related]
16. [Malignant mesothelioma of the pleura: correlations between thoracoscopy and radiology].
Bergonzini R; Olivetti L; Tassi GF; Chiodera PL
Radiol Med; 1996; 92(1-2):52-7. PubMed ID: 8966273
[TBL] [Abstract][Full Text] [Related]
17. Prolonged survival after talc poudrage for malignant pleural mesothelioma: case series.
Aelony Y; Yao JF
Respirology; 2005 Nov; 10(5):649-55. PubMed ID: 16268920
[TBL] [Abstract][Full Text] [Related]
18. Malignant pleural mesothelioma: surgical management in 285 patients.
Schipper PH; Nichols FC; Thomse KM; Deschamps C; Cassivi SD; Allen MS; Pairolero PC
Ann Thorac Surg; 2008 Jan; 85(1):257-64; discussion 264. PubMed ID: 18154820
[TBL] [Abstract][Full Text] [Related]
19. Multimodality treatment of malignant pleural mesothelioma with or without immunotherapy: does it change anything?
Lucchi M; Picchi A; Alí G; Chella A; Guglielmi G; Cristaudo A; Fontanini G; Mussi A
Interact Cardiovasc Thorac Surg; 2010 Apr; 10(4):572-6. PubMed ID: 20053697
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of a liposome-entrapped cisplatin analog (L-NDDP) administered intrapleurally and pathologic response rates in patients with malignant pleural mesothelioma.
Lu C; Perez-Soler R; Piperdi B; Walsh GL; Swisher SG; Smythe WR; Shin HJ; Ro JY; Feng L; Truong M; Yalamanchili A; Lopez-Berestein G; Hong WK; Khokhar AR; Shin DM
J Clin Oncol; 2005 May; 23(15):3495-501. PubMed ID: 15908659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]